Archives
EX 527 and SIRT1 in Aging Bone: Reading the Evidence
2026-11-12
A literature-focused interpretation of how EX 527 (SEN0014196) functioned as a pharmacological SIRT1-inhibition comparator in an aging-bone study, linking SIRT1 activity with type H vessels, osteogenesis, β-catenin signaling, and reciprocal stromal–endothelial communication.
How LNP Chemistry Shapes mRNA Translation
2026-11-12
A mechanistic editorial on how lipid chemistry, nanoparticle attributes, physiological stability, and manufacturing controls shape the translation of mRNA delivery systems, with emphasis on what current review evidence establishes and where interpretation remains limited.
When Context Changes a Yield Result
2026-11-11
A reported 15–20 g/L milk concentration in a targeted rabbit line is best interpreted as a locus- and promoter-specific proof of concept, not a universal production benchmark. The meaning of the result changes with the reporter, genotype, comparator, measurement, and biological context.
Why CSN2 Targeting Raises Rabbit Pharming Yield
2026-11-11
A literature-focused analysis of how endogenous CSN2-locus targeting produced high tdTomato concentrations in rabbit milk, what the study demonstrates, and where its evidence remains limited.
How mRNA–LNP Quality Shapes Translation
2026-11-10
mRNA–lipid nanoparticles succeed when molecular design, particle attributes, physiological behavior, and manufacturing control remain causally aligned. The strongest evidence supports a systems-level interpretation: ionizable lipid chemistry can balance delivery and tolerability, but no single critical quality attribute independently predicts clinical performance.
What High-Yield Rabbit Pharming Evidence Shows
2026-11-10
A 2025 study reports that targeted placement of a reporter gene under the endogenous CSN2 regulatory context produced 15–20 g/L tdTomato in milk from two homozygous rabbits. The result supports a strong locus-and-promoter effect hypothesis, but it does not yet establish equivalent performance for therapeutic proteins, population-wide reproducibility, or manufacturing readiness.
HEPES and the Limits of Rabbit Pharming Evidence
2026-11-09
A targeted rabbit expression study reported unusually high milk concentrations of a fluorescent reporter, but its findings support a narrow promoter-and-locus proof of concept rather than evidence for HEPES, intracellular pH modulation, or therapeutic-protein production in general.
What CMC Determines in mRNA–LNP Translation
2026-11-09
A literature-focused analysis of how lipid chemistry, particle attributes, manufacturing strategy, analytical controls, and physiological stability shape the translation of mRNA lipid nanoparticles from proof of concept to clinical products.
A High-Yield Rabbit Pharming Strategy, Examined
2026-11-08
A literature-focused analysis of a 2025 study that used targeted insertion at the rabbit CSN2 locus to drive tdTomato expression in milk, reporting 15–20 g/L in two homozygous females while highlighting the limits of reporter-based and cross-study comparisons.
Targeted Rabbit Pharming and Milk Yield
2026-11-07
A 2025 study tested whether targeted insertion at the endogenous CSN2 milk-protein locus could improve recombinant protein output in rabbits. Its reported 15–20 g/L tdTomato concentration is promising, but the evidence remains a reporter-based demonstration rather than a controlled validation of therapeutic protein manufacturing.
When Context Changes What a Yield Result Means
2026-11-06
A reported 15–20 g/L milk concentration is meaningful only within the study’s genetic model, reporter choice, comparator, and readout. The rabbit pharming study supports a targeted CSN2-locus proof of concept, while offering no basis for attributing the result to HEPES, intracellular pH modulation, or lysosomal biology.
Targeted Promoters and High-Yield Rabbit Pharming
2026-11-06
A literature-focused analysis of a 2025 study that used targeted insertion at the rabbit CSN2 locus to drive tdTomato expression in milk. The reported 15–20 g/L concentration in two homozygous females is striking, but the evidence remains a proof of concept because it concerns a reporter protein, a small animal cohort, and historical rather than contemporaneous comparisons.
How CSN2 Targeting Raised Rabbit Milk Yield
2026-11-05
A 2025 study examined whether placing a reporter gene at the endogenous rabbit CSN2 milk-protein locus could overcome the variable expression associated with conventional transgenic pharming. The reported 15–20 g/L tdTomato yield in two homozygous animals is substantial, but its interpretation remains bounded by the reporter-only design, small animal-level evidence, and cross-study comparisons.
How CMC Shapes mRNA-LNP Translation
2026-11-05
A mechanistic editorial on how lipid chemistry, nanoparticle attributes, manufacturing comparability and orthogonal analytics shape the translation of mRNA lipid nanoparticles.
What High-Yield Rabbit Pharming Shows
2026-11-04
A targeted rabbit milk-expression study reported recombinant-protein concentrations of 15–20 g/L, but its strongest evidence is a proof-of-concept rather than a definitive demonstration of general superiority. The result supports the importance of genomic context while leaving questions about reproducibility, protein-specific performance, native milk biology and product quality unresolved.